MCCOURT Thomas A's Form 4 filing
Ironwood Pharmaceuticals Inc (IRWD) · filed May 22, 2024
- Accession no.
- 0000950170-24-063485
- Filed
- May 22, 2024
- Trade date
- May 20, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $436.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| MCCOURT Thomas ACIK 0001478448 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 20, 2024 | Class A Common Stock | SSaleDisposed | −67,618 | $6.45 | −$436,136.1 | 1,150,330 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.